Your browser doesn't support javascript.
loading
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Waks, Adrienne G; Stover, Daniel G; Guerriero, Jennifer L; Dillon, Deborah; Barry, William T; Gjini, Evisa; Hartl, Christina; Lo, Wesley; Savoie, Jennifer; Brock, Jane; Wesolowski, Robert; Li, Zaibo; Damicis, Adrienne; Philips, Anne V; Wu, Yun; Yang, Fei; Sullivan, Amy; Danaher, Patrick; Brauer, Heather Ann; Osmani, Wafa; Lipschitz, Mikel; Hoadley, Katherine A; Goldberg, Michael; Perou, Charles M; Rodig, Scott; Winer, Eric P; Krop, Ian E; Mittendorf, Elizabeth A; Tolaney, Sara M.
Afiliação
  • Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stover DG; Division of Medical Oncology, Ohio State University College of Medicine, Columbus, Ohio.
  • Guerriero JL; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Barry WT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gjini E; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hartl C; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lo W; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Savoie J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Brock J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Wesolowski R; Division of Medical Oncology, Ohio State University College of Medicine, Columbus, Ohio.
  • Li Z; Department of Pathology, Ohio State University College of Medicine, Columbus, Ohio.
  • Damicis A; Department of Biostatistics, Ohio State University College of Public Health, Columbus, Ohio.
  • Philips AV; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sullivan A; NanoString Technologies, Seattle, Washington.
  • Danaher P; NanoString Technologies, Seattle, Washington.
  • Brauer HA; NanoString Technologies, Seattle, Washington.
  • Osmani W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lipschitz M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hoadley KA; University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Goldberg M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Perou CM; University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mittendorf EA; Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tolaney SM; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Clin Cancer Res ; 25(15): 4644-4655, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31061067

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Progesterona / Linfócitos do Interstício Tumoral / Receptor ErbB-2 / Terapia Neoadjuvante / Receptor alfa de Estrogênio / Microambiente Tumoral Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Progesterona / Linfócitos do Interstício Tumoral / Receptor ErbB-2 / Terapia Neoadjuvante / Receptor alfa de Estrogênio / Microambiente Tumoral Idioma: En Ano de publicação: 2019 Tipo de documento: Article